OncoGenex Hires Burris
Bothell, WA-based OncoGenex Pharmaceuticals (NASDAQ: OGXI) said today it has hired Michelle Burris as its executive vice president of operations and chief financial officer. Burris most recently served as senior vice president and chief operating officer at Seattle-based Trubion Pharmaceuticals (NASDAQ: TRBN) until it was acquired by Emergent BioSolutions. Burris, a veteran chief financial officer with experience at Dendreon and Corixa, became connected to OncoGenex when she joined the board of Sonus Pharmaceuticals in 2004. She stayed on the OncoGenex board after it acquired Sonus in 2008. She will start at the new company at a flush moment, as it just raised $50 million last month through a securities offering.